Back
Sarepta Therapeutics Vs. Carvana Industry Stock Comparison
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
$128.00
Seasonality Move:
9.24%
Sell
35
CVNA
Carvana
Last Price:
$186.49
Seasonality Move:
28.27%
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $126.29. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Carvana (CVNA)
is a Sell
Is Carvana a Buy, Sell or Hold?
-
CVNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $126.29Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.12 | Buy |
Relative Strength Index (14 RSI): | 56.51 | Buy |
Chaikin Money Flow: | 109207 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (120.86 - 129.32) | Buy |
Bollinger Bands (100): | (117.93 - 133.51) | Buy |
CVNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.86 | Sell |
Relative Strength Index (14 RSI): | 21.13 | Sell |
Chaikin Money Flow: | -9778075 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (213.65 - 257.29) | Sell |
Bollinger Bands (100): | (159.63 - 240.27) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.57 | Buy |
20-day SMA: | 123.78 | Buy |
50-day SMA: | 122.52 | Buy |
200-day SMA: | 129.64 | Sell |
8-day EMA: | 123.22 | Buy |
20-day EMA: | 123.01 | Buy |
50-day EMA: | 123.43 | Buy |
200-day EMA: | 125.73 | Buy |
CVNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 209.53 | Sell |
20-day SMA: | 230.03 | Sell |
50-day SMA: | 235.05 | Sell |
200-day SMA: | 154.5 | Buy |
8-day EMA: | 206.27 | Sell |
20-day EMA: | 222.68 | Sell |
50-day EMA: | 223.47 | Sell |
200-day EMA: | 165.03 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.84 per share, and an increase next year of $4.82 per share.
Carvana Earnings Growth & CVNA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $1.43 per share.
Sarepta Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Carvana Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |